In a CNBC Pro exclusive interview from JPMorgan's Annual Healthcare Conference in San Francisco, Boston Scientific CEO Michael Mahoney gave a revealing update on the company's products.
Boston Scientific is a leading maker of medical devices. During the conversation, Mahoney talked about the market opportunity for the FDA-approved Watchman device, created to reduce the risk of stroke, and its next-generation stent.
Apart from describing these promising developments, Mahoney shared his views on how the company is dealing with rising industry pricing pressure.
Can't see the video? Here's how to become a CNBC Pro subscriber.
